Table 3 Treatment characteristic in STEMI patients with or without cardiac rupture
|  | Non-rupture (n = 885) | Rupture (n = 40) | P value |
|---|---|---|---|
Drugs | |||
 Aspirin | 858 (97.0%) | 33 (82.5%) | 0.006 |
 P2Y12 inhibitor | 850 (96.0%) | 29 (72.5%) | < 0.001 |
 ACEI/ARB | 793 (89.6%) | 13 (32.5%) | < 0.001 |
 β-blocker | 794 (89.7%) | 15 (37.5%) | < 0.001 |
 Statins | 823 (93.0%) | 13 (32.5%) | < 0.001 |
PCI type |  |  | < 0.001 |
 primary PCI | 283 (32.0%) | 12 (30%) |  |
 Delay PCI | 475 (53.7%) | 7 (17.5%) |  |
 Non-PCI | 127 (14.3%) | 21 (52.5%) |  |